Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study

Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employee...

Full description

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 50; no. 5; pp. 1029 - 1034
Main Authors Li, Youming, Xu, Chengfu, Yu, Chaohui, Xu, Lei, Miao, Min
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 01.05.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3±86.6 vs. 321.1±82.6μmol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P<0.001). Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD.
AbstractList BACKGROUND/AIMSerum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD).METHODSA cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China.RESULTSThe study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3+/-86.6 vs. 321.1+/-82.6 micromol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067-1.564; P<0.001).CONCLUSIONSerum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD.
Background/Aim Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). Methods A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. Results The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3 ± 86.6 vs . 321.1 ± 82.6 μmol/L; P < 0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P < 0.001), and the prevalence rate increased with progressively higher serum uric acid levels ( P value for trend < 0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P < 0.001). Conclusion Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD.
Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3±86.6 vs. 321.1±82.6μmol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P<0.001). Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD.
Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3+/-86.6 vs. 321.1+/-82.6 micromol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067-1.564; P<0.001). Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD.
Author Xu, Lei
Xu, Chengfu
Li, Youming
Yu, Chaohui
Miao, Min
Author_xml – sequence: 1
  givenname: Youming
  surname: Li
  fullname: Li, Youming
  email: xiaofu@zju.edu.cn
  organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China
– sequence: 2
  givenname: Chengfu
  surname: Xu
  fullname: Xu, Chengfu
  organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China
– sequence: 3
  givenname: Chaohui
  surname: Yu
  fullname: Yu, Chaohui
  organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China
– sequence: 4
  givenname: Lei
  surname: Xu
  fullname: Xu, Lei
  organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China
– sequence: 5
  givenname: Min
  surname: Miao
  fullname: Miao, Min
  organization: Department of Internal Medicine, The Hospital of Zhenhai Refining & Chemical Company, Ningbo, PR China
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21495706$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19299029$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhS1URKeFF2CBvIFdwrUnydgVqjSq-JMqsQAkdpZj32gcPPFgJ4Pm7XE6QxeVKCsv_J1j33PuBTkbwoCEvGRQMmDN277sN7grOYAoGSuBsydkwRqAApqKnZFFhkQh-Eqck4uUegBYgqyekXMmuZTA5YLYdUrBOD26MNDQ0YRx2tIpOkO1cZZ63KOnv924ofn1QnsTNsHn206P44F6t8dIrUuoE17RNTUxpFQkNLOh9jSNkz08J0877RO-OJ2X5PuH999uPhW3Xz5-vlnfFqaSMBa1aI3WUsuq4i3X1ggUrbW2qtpVVdul4Ubotmk6sRJ8yS1osFDXrQSoMYuWl-TN0XcXw68J06i2Lhn0Xg8YpqSaFatqBjKDr07g1G7Rql10Wx0P6m8uGXh9AnQy2ndRD8ale46zStYraDInjtzd3BE7Zdx4F-YYtfOKgZqrUr2aq1JzVYoxlavKUv5Aev-Lx0TvjiLMMe4dRpWMw8GgdTFnrmxwj8uvH8iNd4PLE_7EA6Y-TDGXlhRTiStQX-cFmvcHRDZp4Ec2uPq3wf9e_wMb19Wk
CODEN JOHEEC
CitedBy_id crossref_primary_10_12996_gmj_galenos_2023_4034
crossref_primary_10_1007_s10620_018_5242_x
crossref_primary_10_1080_17843286_2020_1783907
crossref_primary_10_1186_s12876_020_01189_z
crossref_primary_10_1016_j_jelechem_2016_05_038
crossref_primary_10_1371_journal_pone_0288666
crossref_primary_10_1371_journal_pone_0067152
crossref_primary_10_1021_acs_est_4c00792
crossref_primary_10_3892_br_2016_698
crossref_primary_10_1089_met_2020_0086
crossref_primary_10_3346_jkms_2011_26_3_386
crossref_primary_10_1016_j_jhep_2018_01_019
crossref_primary_10_1016_j_cgh_2021_12_002
crossref_primary_10_1016_j_ijoes_2023_100206
crossref_primary_10_1055_a_1815_7559
crossref_primary_10_1016_j_metabol_2010_08_005
crossref_primary_10_1007_s00394_009_0042_x
crossref_primary_10_1007_s00394_025_03638_5
crossref_primary_10_1016_j_jhep_2015_11_022
crossref_primary_10_1155_2020_5953461
crossref_primary_10_1007_s10800_016_0947_z
crossref_primary_10_1371_journal_pone_0011578
crossref_primary_10_19163_1994_9480_2022_19_2_33_42
crossref_primary_10_1038_s41598_021_88872_7
crossref_primary_10_1155_2016_3805372
crossref_primary_10_1155_2022_6687626
crossref_primary_10_3390_nu15112445
crossref_primary_10_4103_sjg_sjg_484_22
crossref_primary_10_1016_j_metabol_2012_08_013
crossref_primary_10_1186_s12944_017_0531_5
crossref_primary_10_1002_hep4_1199
crossref_primary_10_1097_MEG_0000000000000151
crossref_primary_10_3382_ps_pey596
crossref_primary_10_3389_fmed_2023_1164096
crossref_primary_10_1016_j_biopha_2019_109158
crossref_primary_10_5009_gnl_2010_4_3_378
crossref_primary_10_1016_j_clinbiochem_2015_12_010
crossref_primary_10_1097_MD_0000000000008164
crossref_primary_10_3109_03009741003742797
crossref_primary_10_1111_hepr_12146
crossref_primary_10_1038_srep37288
crossref_primary_10_1097_MD_0000000000026946
crossref_primary_10_1159_000346202
crossref_primary_10_1089_jwh_2012_4043
crossref_primary_10_1093_gastro_goaa035
crossref_primary_10_1016_j_jped_2012_12_008
crossref_primary_10_3109_13697137_2014_926323
crossref_primary_10_3390_ijms232113141
crossref_primary_10_1016_j_atherosclerosis_2018_02_014
crossref_primary_10_1155_2013_564645
crossref_primary_10_1111_j_1478_3231_2012_02842_x
crossref_primary_10_1002_hep_23717
crossref_primary_10_25298_2616_5546_2019_3_2_145_150
crossref_primary_10_1007_s00592_018_1153_8
crossref_primary_10_3390_nu15133022
crossref_primary_10_1074_jbc_M114_549204
crossref_primary_10_1016_j_jceh_2015_02_006
crossref_primary_10_1007_s00204_023_03490_8
crossref_primary_10_1186_1471_230X_12_123
crossref_primary_10_5009_gnl14444
crossref_primary_10_1016_S1499_3872_11_60046_5
crossref_primary_10_1042_BCJ20190873
crossref_primary_10_1186_1476_511X_13_117
crossref_primary_10_1007_s12072_013_9482_8
crossref_primary_10_1186_s12967_018_1657_6
crossref_primary_10_1111_j_1440_1746_2010_06548_x
crossref_primary_10_1517_14728222_2016_1096930
crossref_primary_10_1017_S0029665115002451
crossref_primary_10_1016_j_jfma_2012_11_014
crossref_primary_10_1016_j_jhep_2011_12_025
crossref_primary_10_1038_s41598_024_55845_5
crossref_primary_10_1152_ajpendo_00214_2013
crossref_primary_10_1186_s13098_023_00997_z
crossref_primary_10_1002_advs_202104373
crossref_primary_10_1007_s11745_012_3671_4
crossref_primary_10_1097_FJC_0000000000000406
crossref_primary_10_1074_jbc_RA118_006158
crossref_primary_10_1038_srep38605
crossref_primary_10_1016_j_jpedp_2012_12_011
crossref_primary_10_1097_MD_0000000000023049
crossref_primary_10_1186_s12876_022_02263_4
crossref_primary_10_3390_pharmacy11050151
crossref_primary_10_1136_vr_101237
crossref_primary_10_1371_journal_pone_0140379
crossref_primary_10_1038_s41598_020_57784_3
crossref_primary_10_1016_j_clbc_2017_11_010
crossref_primary_10_1007_s12072_015_9682_5
crossref_primary_10_1093_toxsci_kfab034
crossref_primary_10_3390_jcm12020648
crossref_primary_10_1038_srep14325
crossref_primary_10_1371_journal_pone_0203084
crossref_primary_10_1155_2019_2763093
crossref_primary_10_1186_1471_230X_13_3
crossref_primary_10_1111_hepr_12734
crossref_primary_10_1186_s12967_022_03850_5
crossref_primary_10_1111_cen_12776
crossref_primary_10_1093_qjmed_hcv006
crossref_primary_10_1586_egh_11_19
crossref_primary_10_1111_jgh_12212
crossref_primary_10_1152_ajpendo_00518_2020
crossref_primary_10_1038_s41598_018_30267_2
crossref_primary_10_18410_jebmh_2019_543
crossref_primary_10_1097_MEG_0000000000000434
crossref_primary_10_3899_jrheum_131240
crossref_primary_10_1007_s12072_013_9453_0
crossref_primary_10_3346_jkms_2023_38_e267
crossref_primary_10_1016_j_jhep_2011_05_027
crossref_primary_10_2147_CLEP_S403314
crossref_primary_10_1155_2018_5628749
crossref_primary_10_3390_nu9080878
crossref_primary_10_1089_met_2022_0013
crossref_primary_10_3899_jrheum_180761
crossref_primary_10_1016_j_pharmthera_2024_108615
crossref_primary_10_1016_j_heliyon_2023_e18758
crossref_primary_10_1016_j_clinbiochem_2014_04_026
crossref_primary_10_1371_journal_pone_0034198
crossref_primary_10_24018_ejmed_2020_2_4_351
crossref_primary_10_3389_fendo_2024_1293850
crossref_primary_10_1016_j_jhep_2015_01_019
crossref_primary_10_3389_fendo_2024_1455132
crossref_primary_10_1155_2014_393628
crossref_primary_10_1515_CCLM_2010_037
crossref_primary_10_1136_gutjnl_2017_313884
crossref_primary_10_1016_j_arres_2022_100051
crossref_primary_10_2147_DMSO_S438975
crossref_primary_10_3390_jcm13247616
crossref_primary_10_1111_jgh_12036
crossref_primary_10_3390_ijms17040548
crossref_primary_10_1097_MD_0000000000006381
crossref_primary_10_1111_dom_15466
crossref_primary_10_1016_j_amjms_2017_03_014
crossref_primary_10_1016_j_jpba_2016_12_033
crossref_primary_10_1155_2016_1365257
crossref_primary_10_1186_s12944_018_0762_0
crossref_primary_10_3390_ijerph19031042
crossref_primary_10_1111_liv_13329
crossref_primary_10_1111_hepr_12656
crossref_primary_10_14412_1996_7012_2019_1_114_120
crossref_primary_10_1002_hep_25741
crossref_primary_10_1186_s12944_020_01288_6
crossref_primary_10_3389_fendo_2020_600472
crossref_primary_10_1016_j_cgh_2012_03_011
crossref_primary_10_1111_j_1365_2265_2011_04016_x
crossref_primary_10_1007_s10620_012_2193_5
crossref_primary_10_1111_jgh_12251
crossref_primary_10_1016_j_freeradbiomed_2019_06_019
crossref_primary_10_1038_ajg_2013_104
crossref_primary_10_1155_2016_8603164
crossref_primary_10_20517_mtod_2023_41
crossref_primary_10_1016_j_cld_2012_03_005
crossref_primary_10_1186_s12944_020_01261_3
crossref_primary_10_1111_liv_12842
crossref_primary_10_1136_bmjopen_2020_048574
crossref_primary_10_3945_an_114_008144
crossref_primary_10_1186_s13027_024_00575_6
crossref_primary_10_1016_j_diabet_2010_10_009
crossref_primary_10_3389_fendo_2023_1183666
crossref_primary_10_1097_MEG_0000000000000507
crossref_primary_10_4254_wjh_v6_i5_263
crossref_primary_10_3390_nu11091987
crossref_primary_10_1590_S0004_27302013000800006
crossref_primary_10_3390_ijerph13090841
crossref_primary_10_18632_oncotarget_9691
crossref_primary_10_1038_s41598_024_74841_3
crossref_primary_10_1111_liv_15564
crossref_primary_10_3390_nu6125679
crossref_primary_10_1039_D1FO01517F
crossref_primary_10_1089_end_2020_0486
crossref_primary_10_1074_jbc_M112_399899
crossref_primary_10_1007_s12072_012_9384_1
crossref_primary_10_1590_S0004_27302010000400004
crossref_primary_10_17235_reed_2019_5965_2018
crossref_primary_10_3389_fendo_2022_821689
crossref_primary_10_1111_1440_1681_12011
crossref_primary_10_1210_jc_2011_3010
crossref_primary_10_3748_wjg_v22_i5_1884
crossref_primary_10_1016_j_bioelechem_2012_05_005
crossref_primary_10_1111_j_1365_2036_2011_04788_x
crossref_primary_10_3389_fendo_2020_00179
crossref_primary_10_1038_nrgastro_2013_34
crossref_primary_10_7717_peerj_7563
crossref_primary_10_1002_acr_22729
crossref_primary_10_1007_s11901_015_0264_8
crossref_primary_10_1111_ijpo_238
crossref_primary_10_1038_nrgastro_2013_41
crossref_primary_10_1016_j_ijbiomac_2014_01_025
crossref_primary_10_1016_j_jhep_2015_06_013
crossref_primary_10_1093_aje_kwr291
crossref_primary_10_1038_s41598_025_94118_7
crossref_primary_10_1371_journal_pone_0107882
crossref_primary_10_1038_srep32002
crossref_primary_10_1097_MD_0000000000004293
crossref_primary_10_1186_s12876_025_03598_4
crossref_primary_10_1186_s41043_021_00247_w
crossref_primary_10_1016_j_clinbiochem_2014_01_029
crossref_primary_10_1016_j_jnutbio_2019_05_015
crossref_primary_10_1155_2014_171053
crossref_primary_10_26442_00403660_2022_02_201363
crossref_primary_10_1097_MD_0000000000000802
Cites_doi 10.1016/0895-7061(96)00098-2
10.5551/jat.9.28
10.1001/jama.1993.03510030078038
10.1111/j.1365-2036.2005.02601.x
10.1111/j.1440-1746.2007.05042.x
10.1002/hep.21313
10.1016/j.atherosclerosis.2006.08.021
10.1053/jhep.2003.50161
10.1016/S1590-8658(02)80194-3
10.1111/j.1464-5491.2005.01582.x
10.1002/hep.20781
10.1001/jama.283.18.2404
10.1007/s11892-005-0020-5
10.1291/hypres.30.823
10.1152/physiol.00039.2004
10.1016/j.amjmed.2006.06.040
10.1016/j.jhep.2008.06.012
10.1016/S0021-9150(99)00214-2
10.1053/jhep.2003.50193
10.1194/jlr.M200407-JLR200
10.1161/01.HYP.0000069700.62727.C5
10.1253/circj.69.928
10.1007/BF00296994
10.1016/j.jhep.2005.02.042
10.2337/diabetes.54.12.3541
10.1097/00005344-200109000-00005
10.1080/00365520500319591
10.1111/j.1464-5491.2006.01858.x
10.1186/1743-7075-1-10
10.1016/S0026-0495(99)90163-4
10.1002/hep.20734
10.1111/j.1440-1746.2007.04952.x
10.2337/diabetes.50.8.1844
10.1016/j.jhep.2007.04.012
ContentType Journal Article
Copyright 2008 European Association for the Study of the Liver
European Association for the Study of the Liver
2009 INIST-CNRS
Copyright_xml – notice: 2008 European Association for the Study of the Liver
– notice: European Association for the Study of the Liver
– notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jhep.2008.11.021
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0641
EndPage 1034
ExternalDocumentID 19299029
21495706
10_1016_j_jhep_2008_11_021
S016882780800860X
1_s2_0_S016882780800860X
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D-I
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LZ1
M27
M41
MJL
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
TEORI
UV1
WUQ
X7M
YOC
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c490t-58bcaa9a9442b2adc8e8bddd44b745d3c2c8ab66f878232d0a0d055b9005e9443
IEDL.DBID .~1
ISSN 0168-8278
IngestDate Wed Jul 30 11:32:52 EDT 2025
Mon Jul 21 06:01:12 EDT 2025
Mon Jul 21 09:17:51 EDT 2025
Tue Jul 01 04:14:05 EDT 2025
Thu Apr 24 23:03:57 EDT 2025
Fri Feb 23 02:28:18 EST 2024
Sun Feb 23 10:19:17 EST 2025
Tue Aug 26 16:50:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords SBP
NAFLD
PR
OR
LDL-C
CI
IQR
Uric acid
WC
TC
HDL-C
SD
SE
DBP
TG
Association
GGT
MBP
FPG
Non-alcoholic fatty liver disease
SUA
BMI
triglyceride
non-alcoholic fatty liver disease
prevalence ratio
low-density lipoprotein cholesterol
interquartile range
odds ratio
systolic blood pressure
total cholesterol
diastolic blood pressure
high-density lipoprotein cholesterol
serum uric acid
prevalence rate
waist circumference
body mass index
standard error
confidence interval
γ-glutamyltransferase
fasting plasma glucose
mean blood pressure
standard deviation
Cross sectional study
Non alcoholic steatohepatitis
Gastroenterology
Digestive diseases
Hepatic disease
Serum
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-58bcaa9a9442b2adc8e8bddd44b745d3c2c8ab66f878232d0a0d055b9005e9443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19299029
PQID 67145109
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67145109
pubmed_primary_19299029
pascalfrancis_primary_21495706
crossref_citationtrail_10_1016_j_jhep_2008_11_021
crossref_primary_10_1016_j_jhep_2008_11_021
elsevier_sciencedirect_doi_10_1016_j_jhep_2008_11_021
elsevier_clinicalkeyesjournals_1_s2_0_S016882780800860X
elsevier_clinicalkey_doi_10_1016_j_jhep_2008_11_021
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-05-01
PublicationDateYYYYMMDD 2009-05-01
PublicationDate_xml – month: 05
  year: 2009
  text: 2009-05-01
  day: 01
PublicationDecade 2000
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: Netherlands
PublicationTitle Journal of hepatology
PublicationTitleAlternate J Hepatol
PublicationYear 2009
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Choi, Ford (bib10) 2007; 120
Targher, Arcaro (bib34) 2007; 191
Johnson, Kang, Feig, Kivlighn, Kanellis, Watanabe (bib36) 2003; 41
Waring, Webb, Maxwell (bib28) 2001; 38
Alberti, Zimmet, Shaw (bib14) 2006; 23
Hayden, Tyagi (bib31) 2004; 1
Rahmouni, Haynes (bib25) 2005; 5
Lonardo, Loria, Leonardi, Borsatti, Neri, Pulvirenti (bib11) 2002; 34
Villanova, Moscatiello, Ramilli, Bugianesi, Magalotti, Vanni (bib33) 2005; 42
Neuschwander-Tetri, Caldwell (bib2) 2003; 37
Fang, Alderman (bib18) 2000; 283
Garcia-Ruiz, Rodriguez-Juan, Diaz-Sanjuan, del Hoyo, Colina, Munoz-Yague (bib30) 2006; 44
Amarapurkar, Hashimoto, Lesmana, Sollano, Chen, Goh (bib4) 2007; 22
Muscelli, Natali, Bianchi, Bigazzi, Galvan, Sironi (bib22) 1996; 9
Hediger, Johnson, Miyazaki, Endou (bib7) 2005; 20
Nieto, Iribarren, Gross, Comstock, Cutler (bib27) 2000; 148
Cerda, Perez-Ayuso, Riquelme, Soza, Villaseca, Sir-Petermann (bib17) 2007; 47
Jimba, Nakagami, Takahashi, Wakamatsu, Hirota, Iwamoto (bib1) 2005; 22
Albano, Mottaran, Occhino, Reale, Vidali (bib29) 2005; 22 Suppl 2
Fan, Zhu, Li, Chen, Li, Dai (bib3) 2005; 43
Patterson, Horsley, Leake (bib32) 2003; 44
Marchesini, Bugianesi, Forlani, Cerrelli, Lenzi, Manini (bib5) 2003; 37
Quinones Galvan, Natali, Baldi, Frascerra, Sanna, Ciociaro (bib21) 1995; 268
Baba, Amasaki, Soda, Hida, Imaizumi, Ichimaru (bib13) 2007; 30
Lee, Jin Kim, Yong Jeon, Hoi Kim, Woo Oh, Park (bib12) 2006; 41
Sookoian, Pirola (bib35) 2008; 49
Targher, Bertolini, Poli, Rodella, Scala, Tessari (bib15) 2005; 54
Fruehwald-Schultes, Peters, Kern, Beyer, Pfutzner (bib23) 1999; 48
Marchesini, Brizi, Bianchi, Tomassetti, Bugianesi, Lenzi (bib6) 2001; 50
Matsubara, Chiba, Maruoka, Katayose (bib24) 2002; 9
Fan, Saibara, Chitturi, Kim, Sung, Chutaputti (bib19) 2007; 22
Bedogni, Miglioli, Masutti, Tiribelli, Marchesini, Bellentani (bib16) 2005; 42
Modan, Halkin, Karasik, Lusky (bib20) 1987; 30
Yoo, Sung, Shin, Kim, Kim, Kang (bib8) 2005; 69
Hjortnaes, Algra, Olijhoek, Huisman, Jacobs, van der Graaf (bib9) 2007; 34
Cappuccio, Strazzullo, Farinaro, Trevisan (bib26) 1993; 270
Amarapurkar (10.1016/j.jhep.2008.11.021_bib4) 2007; 22
Villanova (10.1016/j.jhep.2008.11.021_bib33) 2005; 42
Jimba (10.1016/j.jhep.2008.11.021_bib1) 2005; 22
Alberti (10.1016/j.jhep.2008.11.021_bib14) 2006; 23
Marchesini (10.1016/j.jhep.2008.11.021_bib5) 2003; 37
Marchesini (10.1016/j.jhep.2008.11.021_bib6) 2001; 50
Lee (10.1016/j.jhep.2008.11.021_bib12) 2006; 41
Baba (10.1016/j.jhep.2008.11.021_bib13) 2007; 30
Matsubara (10.1016/j.jhep.2008.11.021_bib24) 2002; 9
Rahmouni (10.1016/j.jhep.2008.11.021_bib25) 2005; 5
Quinones Galvan (10.1016/j.jhep.2008.11.021_bib21) 1995; 268
Albano (10.1016/j.jhep.2008.11.021_bib29) 2005; 22 Suppl 2
Lonardo (10.1016/j.jhep.2008.11.021_bib11) 2002; 34
Cappuccio (10.1016/j.jhep.2008.11.021_bib26) 1993; 270
Cerda (10.1016/j.jhep.2008.11.021_bib17) 2007; 47
Hediger (10.1016/j.jhep.2008.11.021_bib7) 2005; 20
Targher (10.1016/j.jhep.2008.11.021_bib15) 2005; 54
Hayden (10.1016/j.jhep.2008.11.021_bib31) 2004; 1
Patterson (10.1016/j.jhep.2008.11.021_bib32) 2003; 44
Fruehwald-Schultes (10.1016/j.jhep.2008.11.021_bib23) 1999; 48
Targher (10.1016/j.jhep.2008.11.021_bib34) 2007; 191
Hjortnaes (10.1016/j.jhep.2008.11.021_bib9) 2007; 34
Choi (10.1016/j.jhep.2008.11.021_bib10) 2007; 120
Yoo (10.1016/j.jhep.2008.11.021_bib8) 2005; 69
Fan (10.1016/j.jhep.2008.11.021_bib3) 2005; 43
Fan (10.1016/j.jhep.2008.11.021_bib19) 2007; 22
Nieto (10.1016/j.jhep.2008.11.021_bib27) 2000; 148
Sookoian (10.1016/j.jhep.2008.11.021_bib35) 2008; 49
Fang (10.1016/j.jhep.2008.11.021_bib18) 2000; 283
Johnson (10.1016/j.jhep.2008.11.021_bib36) 2003; 41
Neuschwander-Tetri (10.1016/j.jhep.2008.11.021_bib2) 2003; 37
Modan (10.1016/j.jhep.2008.11.021_bib20) 1987; 30
Garcia-Ruiz (10.1016/j.jhep.2008.11.021_bib30) 2006; 44
Bedogni (10.1016/j.jhep.2008.11.021_bib16) 2005; 42
Muscelli (10.1016/j.jhep.2008.11.021_bib22) 1996; 9
Waring (10.1016/j.jhep.2008.11.021_bib28) 2001; 38
References_xml – volume: 44
  start-page: 512
  year: 2003
  end-page: 521
  ident: bib32
  article-title: Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid
  publication-title: J Lipid Res
– volume: 148
  start-page: 131
  year: 2000
  end-page: 139
  ident: bib27
  article-title: Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
  publication-title: Atherosclerosis
– volume: 9
  start-page: 28
  year: 2002
  end-page: 34
  ident: bib24
  article-title: Elevated serum leptin concentrations in women with hyperuricemia
  publication-title: J Atheroscler Thromb
– volume: 1
  start-page: 10
  year: 2004
  ident: bib31
  article-title: Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
  publication-title: Nutr Metab (Lond)
– volume: 23
  start-page: 469
  year: 2006
  end-page: 480
  ident: bib14
  article-title: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation
  publication-title: Diabet Med
– volume: 5
  start-page: 260
  year: 2005
  end-page: 266
  ident: bib25
  article-title: Endothelial effects of leptin: implications in health and diseases
  publication-title: Curr Diab Rep
– volume: 30
  start-page: 713
  year: 1987
  end-page: 718
  ident: bib20
  article-title: Elevated serum uric acid–a facet of hyperinsulinaemia
  publication-title: Diabetologia
– volume: 37
  start-page: 917
  year: 2003
  end-page: 923
  ident: bib5
  article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
  publication-title: Hepatology
– volume: 38
  start-page: 365
  year: 2001
  end-page: 371
  ident: bib28
  article-title: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
  publication-title: J Cardiovasc Pharmacol
– volume: 43
  start-page: 508
  year: 2005
  end-page: 514
  ident: bib3
  article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
  publication-title: J Hepatol
– volume: 22 Suppl 2
  start-page: 71
  year: 2005
  end-page: 73
  ident: bib29
  article-title: Review article: role of oxidative stress in the progression of non-alcoholic steatosis
  publication-title: Aliment Pharmacol Ther
– volume: 22
  start-page: 794
  year: 2007
  end-page: 800
  ident: bib19
  article-title: What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
  publication-title: J Gastroenterol Hepatol
– volume: 48
  start-page: 677
  year: 1999
  end-page: 680
  ident: bib23
  article-title: Serum leptin is associated with serum uric acid concentrations in humans
  publication-title: Metabolism
– volume: 22
  start-page: 1141
  year: 2005
  end-page: 1145
  ident: bib1
  article-title: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
  publication-title: Diabet Med
– volume: 22
  start-page: 788
  year: 2007
  end-page: 793
  ident: bib4
  article-title: How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
  publication-title: J Gastroenterol Hepatol
– volume: 270
  start-page: 354
  year: 1993
  end-page: 359
  ident: bib26
  article-title: Uric acid metabolism and tubular sodium handling. Results from a population-based study
  publication-title: JAMA
– volume: 20
  start-page: 125
  year: 2005
  end-page: 133
  ident: bib7
  article-title: Molecular physiology of urate transport
  publication-title: Physiology (Bethesda)
– volume: 44
  start-page: 581
  year: 2006
  end-page: 591
  ident: bib30
  article-title: Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
  publication-title: Hepatology
– volume: 37
  start-page: 1202
  year: 2003
  end-page: 1219
  ident: bib2
  article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  publication-title: Hepatology
– volume: 50
  start-page: 1844
  year: 2001
  end-page: 1850
  ident: bib6
  article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  publication-title: Diabetes
– volume: 283
  start-page: 2404
  year: 2000
  end-page: 2410
  ident: bib18
  article-title: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey
  publication-title: JAMA
– volume: 49
  start-page: 600
  year: 2008
  end-page: 607
  ident: bib35
  article-title: Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
  publication-title: J Hepatol
– volume: 9
  start-page: 746
  year: 1996
  end-page: 752
  ident: bib22
  article-title: Effect of insulin on renal sodium and uric acid handling in essential hypertension
  publication-title: Am J Hypertens
– volume: 120
  start-page: 442
  year: 2007
  end-page: 447
  ident: bib10
  article-title: Prevalence of the metabolic syndrome in individuals with hyperuricemia
  publication-title: Am J Med
– volume: 47
  start-page: 412
  year: 2007
  end-page: 417
  ident: bib17
  article-title: Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
  publication-title: J Hepatol
– volume: 54
  start-page: 3541
  year: 2005
  end-page: 3546
  ident: bib15
  article-title: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
  publication-title: Diabetes
– volume: 69
  start-page: 928
  year: 2005
  end-page: 933
  ident: bib8
  article-title: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome
  publication-title: Circ J
– volume: 41
  start-page: 566
  year: 2006
  end-page: 572
  ident: bib12
  article-title: Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study
  publication-title: Scand J Gastroenterol
– volume: 42
  start-page: 44
  year: 2005
  end-page: 52
  ident: bib16
  article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
  publication-title: Hepatology
– volume: 42
  start-page: 473
  year: 2005
  end-page: 480
  ident: bib33
  article-title: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 41
  start-page: 1183
  year: 2003
  end-page: 1190
  ident: bib36
  article-title: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
  publication-title: Hypertension
– volume: 34
  start-page: 1882
  year: 2007
  end-page: 1887
  ident: bib9
  article-title: Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome
  publication-title: J Rheumatol
– volume: 30
  start-page: 823
  year: 2007
  end-page: 829
  ident: bib13
  article-title: Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki
  publication-title: Hypertens Res
– volume: 191
  start-page: 235
  year: 2007
  end-page: 240
  ident: bib34
  article-title: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
  publication-title: Atherosclerosis
– volume: 268
  start-page: E1
  year: 1995
  end-page: E5
  ident: bib21
  article-title: Effect of insulin on uric acid excretion in humans
  publication-title: Am J Physiol
– volume: 34
  start-page: 204
  year: 2002
  end-page: 211
  ident: bib11
  article-title: Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study
  publication-title: Dig Liver Dis
– volume: 9
  start-page: 746
  year: 1996
  ident: 10.1016/j.jhep.2008.11.021_bib22
  article-title: Effect of insulin on renal sodium and uric acid handling in essential hypertension
  publication-title: Am J Hypertens
  doi: 10.1016/0895-7061(96)00098-2
– volume: 9
  start-page: 28
  year: 2002
  ident: 10.1016/j.jhep.2008.11.021_bib24
  article-title: Elevated serum leptin concentrations in women with hyperuricemia
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.9.28
– volume: 270
  start-page: 354
  year: 1993
  ident: 10.1016/j.jhep.2008.11.021_bib26
  article-title: Uric acid metabolism and tubular sodium handling. Results from a population-based study
  publication-title: JAMA
  doi: 10.1001/jama.1993.03510030078038
– volume: 22 Suppl 2
  start-page: 71
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib29
  article-title: Review article: role of oxidative stress in the progression of non-alcoholic steatosis
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2005.02601.x
– volume: 22
  start-page: 788
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib4
  article-title: How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.05042.x
– volume: 44
  start-page: 581
  year: 2006
  ident: 10.1016/j.jhep.2008.11.021_bib30
  article-title: Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
  publication-title: Hepatology
  doi: 10.1002/hep.21313
– volume: 191
  start-page: 235
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib34
  article-title: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.08.021
– volume: 37
  start-page: 917
  year: 2003
  ident: 10.1016/j.jhep.2008.11.021_bib5
  article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50161
– volume: 34
  start-page: 204
  year: 2002
  ident: 10.1016/j.jhep.2008.11.021_bib11
  article-title: Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study
  publication-title: Dig Liver Dis
  doi: 10.1016/S1590-8658(02)80194-3
– volume: 22
  start-page: 1141
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib1
  article-title: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2005.01582.x
– volume: 42
  start-page: 473
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib33
  article-title: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.20781
– volume: 283
  start-page: 2404
  year: 2000
  ident: 10.1016/j.jhep.2008.11.021_bib18
  article-title: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey
  publication-title: JAMA
  doi: 10.1001/jama.283.18.2404
– volume: 5
  start-page: 260
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib25
  article-title: Endothelial effects of leptin: implications in health and diseases
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-005-0020-5
– volume: 30
  start-page: 823
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib13
  article-title: Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki
  publication-title: Hypertens Res
  doi: 10.1291/hypres.30.823
– volume: 20
  start-page: 125
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib7
  article-title: Molecular physiology of urate transport
  publication-title: Physiology (Bethesda)
  doi: 10.1152/physiol.00039.2004
– volume: 120
  start-page: 442
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib10
  article-title: Prevalence of the metabolic syndrome in individuals with hyperuricemia
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2006.06.040
– volume: 49
  start-page: 600
  year: 2008
  ident: 10.1016/j.jhep.2008.11.021_bib35
  article-title: Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.06.012
– volume: 148
  start-page: 131
  year: 2000
  ident: 10.1016/j.jhep.2008.11.021_bib27
  article-title: Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(99)00214-2
– volume: 37
  start-page: 1202
  year: 2003
  ident: 10.1016/j.jhep.2008.11.021_bib2
  article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50193
– volume: 44
  start-page: 512
  year: 2003
  ident: 10.1016/j.jhep.2008.11.021_bib32
  article-title: Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M200407-JLR200
– volume: 41
  start-page: 1183
  year: 2003
  ident: 10.1016/j.jhep.2008.11.021_bib36
  article-title: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000069700.62727.C5
– volume: 69
  start-page: 928
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib8
  article-title: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome
  publication-title: Circ J
  doi: 10.1253/circj.69.928
– volume: 30
  start-page: 713
  year: 1987
  ident: 10.1016/j.jhep.2008.11.021_bib20
  article-title: Elevated serum uric acid–a facet of hyperinsulinaemia
  publication-title: Diabetologia
  doi: 10.1007/BF00296994
– volume: 43
  start-page: 508
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib3
  article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.02.042
– volume: 54
  start-page: 3541
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib15
  article-title: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.12.3541
– volume: 38
  start-page: 365
  year: 2001
  ident: 10.1016/j.jhep.2008.11.021_bib28
  article-title: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-200109000-00005
– volume: 41
  start-page: 566
  year: 2006
  ident: 10.1016/j.jhep.2008.11.021_bib12
  article-title: Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365520500319591
– volume: 268
  start-page: E1
  year: 1995
  ident: 10.1016/j.jhep.2008.11.021_bib21
  article-title: Effect of insulin on uric acid excretion in humans
  publication-title: Am J Physiol
– volume: 23
  start-page: 469
  year: 2006
  ident: 10.1016/j.jhep.2008.11.021_bib14
  article-title: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2006.01858.x
– volume: 1
  start-page: 10
  year: 2004
  ident: 10.1016/j.jhep.2008.11.021_bib31
  article-title: Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
  publication-title: Nutr Metab (Lond)
  doi: 10.1186/1743-7075-1-10
– volume: 48
  start-page: 677
  year: 1999
  ident: 10.1016/j.jhep.2008.11.021_bib23
  article-title: Serum leptin is associated with serum uric acid concentrations in humans
  publication-title: Metabolism
  doi: 10.1016/S0026-0495(99)90163-4
– volume: 42
  start-page: 44
  year: 2005
  ident: 10.1016/j.jhep.2008.11.021_bib16
  article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study
  publication-title: Hepatology
  doi: 10.1002/hep.20734
– volume: 34
  start-page: 1882
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib9
  article-title: Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome
  publication-title: J Rheumatol
– volume: 22
  start-page: 794
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib19
  article-title: What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.04952.x
– volume: 50
  start-page: 1844
  year: 2001
  ident: 10.1016/j.jhep.2008.11.021_bib6
  article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.8.1844
– volume: 47
  start-page: 412
  year: 2007
  ident: 10.1016/j.jhep.2008.11.021_bib17
  article-title: Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2007.04.012
SSID ssj0003094
Score 2.4133286
Snippet Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the...
Background/Aim Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to...
BACKGROUND/AIMSerum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1029
SubjectTerms Adult
Association
Biological and medical sciences
Biomarkers - blood
China - epidemiology
Cross-Sectional Studies
Fatty Liver - blood
Fatty Liver - epidemiology
Fatty Liver - ethnology
Female
Gastroenterology and Hepatology
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Metabolic Syndrome - blood
Metabolic Syndrome - epidemiology
Metabolic Syndrome - ethnology
Middle Aged
Non-alcoholic fatty liver disease
Other diseases. Semiology
Prevalence
Regression Analysis
Risk Factors
Uric acid
Uric Acid - blood
Title Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S016882780800860X
https://www.clinicalkey.es/playcontent/1-s2.0-S016882780800860X
https://dx.doi.org/10.1016/j.jhep.2008.11.021
https://www.ncbi.nlm.nih.gov/pubmed/19299029
https://www.proquest.com/docview/67145109
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi4SQEOJNeRQfuCFTx3HimFtVsSqPXSFgpd4sO3ZEV6WtSHrgwm9nJna6rGAXiVOkxKM44_H4c_zNDCEvame9CDowXyvFwPsF5lzumfBZLWqvPNcY73x8Us5P5btFsTggsyEWBmmVyfdHn95763RnkrQ52S6Xk88AVgAeKkyMCLicLzCCXSq08lc_z2keOdcpv3fFsHUKnIkcr7OvYRv5lJjJU2SXLU43t7YFlTWx1sXlYLRflI5uk1sJTdJp7PAdchDWd8n143Refo_437RPNw0Fe9t9o5hIiNp66ekKKUMU_8XS9WbNbKyXC08b23U_6ApJGzSd4bymU9p3m7U9fQtf3CenvU9Oj958mc1ZqqvAaql5x4rK1dZqq6UUTlhfV6Fy3nspnZKFz2GQKuvKsqkAPuTCc8s9LwqnYcYGEMofkEPoVHhEKLTKRCNkUzstC5ADvKCxqlXpLLdKj0g2KNTUKek41r5YmYFddmZwEGI1TNiLwCCMyMu9zDam3LiydT6MkxmCScH9GVgRrpRSf5MKbZrBrclMKww3f1jZiBR7yQuG-s83ji8Y0f7TBO5RFS9H5PlgVQamOJ7b2HXY7FpTKiynzEGZD6OxnatFI5oQ-vF_duoJuRFPx5DA-ZQcdt934RmArM6N-1k0Jtems08fPuL17fv5yS_A9yf7
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkQAJId4sj9YHbsis4zgPc6sqqgW6vdBKe7P8irrVsrsi2QMXfjszsbOlghaJa-KRnfHM-HP8eYaQt84aL4IKzLuqYhD9ArM290z4zAnnK88V3neenpSTM_l5Vsx2yOFwFwZplSn2x5jeR-v0ZJy0OV7P5-OvAFYAHlaYGBFwOZ_dIrcluC-WMXj_85LnkXOVEnzXDJunmzOR5HVxHtaRUImpPEV23ep0f21a0FkTi11cj0b7VenoIXmQ4CQ9iCN-RHbC8jG5M00H5k-I_039dNVQMLjNN4qZhKhxc08XyBmi-DOWLldLZmLBXHjbmK77QRfI2qDpEOcDPaD9sFnb87ew4z477VNydvTx9HDCUmEF5qTiHStq64xRRkkprDDe1aG23nspbSULn8Ms1caWZVMDfsiF54Z7XhRWgcsGEMqfkV0YVHhBKLTKRCNk46ySBcgBYFBY1qq0hptKjUg2KFS7lHUci18s9EAvu9A4CbEcJmxGYBJG5N1WZh1zbtzYOh_mSQ-3SSH-aVgSbpSq_iYV2uTCrc50KzTXf5jZiBRbySuW-s8e964Y0fbTBG5SK16OyP5gVRp8HA9uzDKsNq0uK6ynzEGZz6OxXapFIZwQ6uV_Dmqf3J2cTo_18aeTL6_IvXhUhmzO12S3-74JbwBxdXav96hfA-8n9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+serum+uric+acid+level+with+non-alcoholic+fatty+liver+disease%3A+a+cross-sectional+study&rft.jtitle=Journal+of+hepatology&rft.au=Li%2C+Youming&rft.au=Xu%2C+Chengfu&rft.au=Yu%2C+Chaohui&rft.au=Xu%2C+Lei&rft.date=2009-05-01&rft.eissn=1600-0641&rft.volume=50&rft.issue=5&rft.spage=1029&rft.epage=1034&rft_id=info:doi/10.1016%2Fj.jhep.2008.11.021&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827809X00048%2Fcov150h.gif